Does glucosamine accelerate Alzheimer’s? A big claim, a small denominator
The First Oral Carbapenem Arrives - Tebipenem pivoxil (Utebzi): what it is, where it earns its place, and where it absolutely does not
Baxdrostat vs. Spironolactone: A New Mechanism Meets an Old Bargain - THE $5-BILLION QUESTION
IV Iron in Oncology: Time to Rethink Your Default
When the New β-Lactam/β-Lactamase Inhibitors Aren’t Enough
Asundexian for Secondary Stroke Prevention OCEANIC-STROKE — A Three-Lens Critical Appraisal
OCEANIC-STROKE met its primary endpoint with a 26% relative reduction in ischemic stroke and no excess major bleeding — but the prespecified hierarchy broke at the 90-day endpoint. A statistician, a neurologist, and a researcher walk into a journal club. Here's what they each see.
Beyond Weight Loss: Reading the GLP-1 Side Effect Profile in Real Numbers A field guide for clinicians who are tired of being shown hazard ratios without denominators.
The Aspiration Anaerobe Myth What actually colonizes the aerodigestive tract — and why reflexive Zosyn for “possible aspiration” fails basic microbiology
Flecainide After PCI: 35 Years After CAST, Is It Time to Reconsider Class Ic Antiarrhythmics in Coronary Artery Disease?
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
Surviving Sepsis Campaign 2026: A Comprehensive Pharmacotherapy Review
The SSC 2026 Guidelines represent the most comprehensive sepsis update since 2021 — with major changes to antibiotic selection, vasopressor targets, fluid resuscitation, and a new strong recommendation for prolonged beta-lactam infusion.